No Waitlists, No Pharmacies: AM Rx Brings Same-Day GLP-1 Weight Loss Consultations to Patients Nationwide
AM Rx weight loss program offers eligible patients across the United States access to clinician-prescribed semaglutide and tirzepatide treatment options, along with oral GLP-1 alternatives, through a streamlined telehealth platform with same-day appointments and individualized care plans.
NEW YORK CITY, NY / ACCESS Newswire / May 4, 2026 / AM Rx, a personalized telehealth and weight loss platform, today announced the nationwide expansion of its AM Rx weight loss program, providing eligible patients across the United States with broader telehealth access to clinician-prescribed GLP-1 medications. Through a streamlined digital care experience, affiliated licensed medical providers evaluate eligible members and determine appropriate treatment options based on each patient's clinical profile, medical history, and individual health goals.
The expansion of the AM Rx weight loss telehealth program comes as patient demand for online weight loss treatment and clinician-guided GLP-1 medications continues to grow across the country. Many patients exploring online weight loss programs still face barriers that include elevated out-of-pocket costs, limited provider access, and confusing treatment pathways. The AM Rx weight loss platform is designed to help reduce those access challenges by combining licensed clinical evaluation, individualized treatment planning, and ongoing patient support within a single online experience.
GLP-1 Treatment Options Available Through the AM Rx Weight Loss Program
The AM Rx weight loss program offers eligible patients access to a range of clinician-prescribed GLP-1 medications when clinically appropriate. Prescribing decisions are made by affiliated licensed providers on an individual, case-by-case basis following a thorough medical evaluation. Treatment categories available through the AM Rx weight loss platform include:
Semaglutide - a GLP-1 receptor agonist prescribed for chronic weight management and metabolic health support in eligible adults, available in injectable form for qualifying AM Rx members.
Tirzepatide - a dual GIP and GLP-1 receptor agonist prescribed for chronic weight management and individualized care plans, including for eligible patients with broader metabolic or diabetes-related considerations.
Oral semaglutide - a non-injectable alternative for patients who prefer a pill-based route to GLP-1 therapy when clinically appropriate based on provider evaluation.
By offering both injectable and oral GLP-1 treatment pathways, the AM Rx weight loss telehealth program supports a wider range of patient preferences and clinical needs. All medications are prescribed only after an independent medical evaluation by a licensed provider, and prescriptions are not guaranteed. Treatment eligibility is determined on a case-by-case basis.
How the AM Rx Weight Loss Program Works
The AM Rx weight loss program is built around convenience, flexibility, and ongoing patient support. The patient enrollment process is designed to be straightforward, with multiple touchpoints for clinical evaluation and follow-up care:
Online medical intake - Patients complete a confidential online intake form that captures medical history, current medications, weight loss goals, and other clinical information needed for provider review.
Provider evaluation - Affiliated licensed medical providers review each patient's information and determine whether GLP-1 treatment may be clinically appropriate. AM Rx offers same-day appointment availability for eligible patients.
Individualized treatment planning - Rather than applying a one-size-fits-all approach, the AM Rx weight loss program tailors treatment plans to each patient's clinical profile, preferences, and health goals.
Ongoing care and follow-up - Patients receive continued provider engagement throughout their treatment journey, with check-ins, dosing adjustments where appropriate, and access to clinical support as needed.
The AM Rx weight loss platform is designed to give eligible patients a clear pathway from initial intake to ongoing care, removing many of the administrative steps that can delay traditional in-person treatment access.
A Personalized Approach to Online Weight Loss Care
AM Rx says its weight loss program reflects continued patient interest in online weight loss programs, GLP-1 telehealth services, and individualized metabolic care. Rather than offering a uniform treatment package, the AM Rx weight loss platform is structured around clinical individualization - with affiliated providers determining the appropriate treatment pathway for each patient based on health history and goals.
The company says it intends to continue refining its clinical workflows and treatment options to meet evolving patient needs in the chronic weight management and metabolic health categories.
Eligibility, Safety, and Provider Oversight
All AM Rx weight loss treatment plans are determined by independent licensed clinicians based on individual patient eligibility, medical history, and applicable clinical guidelines. GLP-1 medications are not appropriate for every patient, and prescriptions through the AM Rx weight loss program are not guaranteed. Patients are encouraged to discuss potential benefits, side effects, contraindications, and treatment alternatives with their provider before beginning any new clinical program.
About AM Rx
AM Rx is a personalized telehealth and weight loss platform offering eligible patients online access to clinician-prescribed treatment programs, including its AM Rx weight loss program for chronic weight management and metabolic health. The platform connects qualifying patients with affiliated licensed medical providers, supports individualized care planning, and provides ongoing clinical engagement throughout the treatment journey. For more information about AM Rx and the AM Rx weight loss program, visit getamrx.com.
Media Contact
Company: AM Rx
Contact Name: Tom Harding
Email: [email protected]
Phone: 877-870-3231
Address: 30 Irving Pl, New York, NY 10003
Website: https://getamrx.com
SOURCE: Am Rx